CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bharat Parenterals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bharat Parenterals Ltd
144-146VILL Haripura Ta Savli
Jarod Samlaya Road
Phone: +91 2667251680p:+91 2667251680 VADODARA, 391520  India Ticker: 541096541096
Business Summary
Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company is engaged in research, development, manufacturing, marketing, sourcing and distribution of pharmaceutical products. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Managing Director, Executive Chairman of the Board Bharatkumar R.Desai 9/3/1992 9/3/1992
Chief Financial Officer Jignesh N.Shah 8/14/2020 8/14/2020
Compliance Officer, Company Secretary Krutika P.Bhattbhatt 10/2/2023 10/2/2023
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 241 (As of 3/31/2022)
Outstanding Shares: 5,819,666 (As of 9/30/2023)
Stock Exchange: BOM
Fax Number: +91 2667251679


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024